Form 4: Northrop Grumman CEO Kathy Warden Reports Stock Transactions

Sentiment:

SEC Form 4


Kathy Warden, Chair, CEO, and President of Northrop Grumman, reports acquisition and disposal of common stock and derivative securities, including Restricted Performance Stock Rights (RPSRs) and Restricted Stock Rights (RSRs).

Summary

  • Kathy Warden, the Chair, CEO, and President of Northrop Grumman, filed a Form 4 detailing changes in beneficial ownership of company stock.
  • On February 18, 2025, Warden acquired 27,350.27 shares of common stock through the vesting of Restricted Performance Stock Rights (RPSRs) and 11,672 shares through the vesting of Restricted Stock Rights (RSRs).
  • Also on February 18, 2025, Warden disposed of 12,335 shares of common stock to cover tax obligations at a price of $441.36 per share related to the vesting of RPSRs and 4,925 shares of common stock to cover tax obligations at a price of $441.36 per share related to the vesting of RSRs.
  • Warden was also granted 27,417.27 Restricted Performance Stock Rights and 11,752 Restricted Stock Rights under the 2024 Long-Term Incentive Stock Plan.
  • Following these transactions, Warden directly owns 216,602.4 shares of common stock.
  • Warden also holds 73,279 Restricted Performance Stock Rights and 33,667 Restricted Stock Rights.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine stock transactions related to executive compensation. There are no explicit positive or negative indicators about the company's performance.

Positives

  • The vesting of stock rights indicates that performance metrics were likely met, which is a positive signal.

Negatives

  • The disposal of shares to cover tax obligations, while standard, slightly reduces Warden's direct holdings.

Risks

  • Future performance metrics not being met could impact the value of unvested Restricted Performance Stock Rights.
  • Changes in tax laws could affect the amount of shares needed to be disposed of to cover tax obligations in the future.

Future Outlook

The document details future vesting dates for Restricted Stock Rights and measurement periods for Restricted Performance Stock Rights, indicating future potential stock acquisitions.

Industry Context

Executive stock transactions are common in publicly traded companies and are closely monitored by investors for insights into management's confidence in the company's future performance. This filing is a routine disclosure.

Comparison to Industry Standards

  • Executive compensation packages at companies like Lockheed Martin (LMT) and Boeing (BA) also include stock options and restricted stock units as part of their long-term incentive plans.
  • The vesting schedules and performance metrics associated with these equity grants are typically aligned with industry best practices to incentivize executive performance and shareholder value creation.
  • The size of the grants and the proportion of equity-based compensation are generally comparable to those of peer companies in the aerospace and defense sector.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
  • Employees may be indirectly affected as executive incentives are aligned with company performance.

Key Dates

DateDescription
02/15/2022Grant date of RPSRs under the 2011 LTISP with a measurement period ended 12/31/24.
02/16/2023Grant date of RPSRs under the 2011 LTISP with a measurement period ending 12/31/25.
02/14/2024Grant date of RPSRs under the 2011 LTISP with a measurement period ending 12/31/26.
12/31/2024Measurement period end date for RPSRs granted on 2/15/22.
02/18/2025Date of the reported transactions: acquisition and disposal of shares, and grant of new RPSRs and RSRs.
02/18/2025Vesting date of RSRs granted under the 2011 LTISP on 2/15/22.
12/31/2027Measurement period end date for RPSRs granted on 2/18/25.
02/18/2028Vesting date of RSRs granted under the 2024 LTISP on 2/18/25.

Keywords

Northrop Grumman, Kathy Warden, Form 4, Stock Options, Restricted Stock Rights, RPSR, RSR, Beneficial Ownership, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.